Voretigene neparvovec for treating inherited retinal dystrophies caused by RPE65 gene mutations. NICE highly specialised technologies guidance 11
National Institute for Health and Care Excellence (NICE)
Record ID 32018014154
English
Details
Project Status:
Completed
URL for project:
https://www.nice.org.uk/guidance/hst11
Year Published:
2019
URL for published report:
https://www.nice.org.uk/guidance/hst11
English language abstract:
An English language summary is available
Publication Type:
Full HTA
Country:
England
MeSH Terms
- Retinal Dystrophies
- Genetic Therapy
- cis-trans-Isomerases
Contact
Organisation Name:
National Institute for Health and Care Excellence
Contact Address:
Level 1A, City Tower, Piccadilly Plaza, Manchester, M1 4BT
Contact Name:
nice@nice.nhs.uk
Contact Email:
nice@nice.nhs.uk
Copyright:
National Institute for Health and Care Excellence (NICE)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.